Search research articles
Contact Us
Filters
Showing results (101-110 of 107) with videos related to
Page
of 11
Sort By:
You have reached the last page of results.
This site can display upto 107 results.
The American Journal of Cardiology
|
August 3, 2014
Preclinical left ventricular diastolic dysfunction in metabolic syndrome
Nir Ayalon, Deepa M Gopal, Deirdre M Mooney, et al.
Lancet (London, England)
|
January 22, 2008
Results of a non-specific immunomodulation therapy in chronic heart failure (ACCLAIM trial): a placebo-controlled randomised trial
Guillermo Torre-Amione, Stefan D Anker, Robert C Bourge, et al.
Nature Reviews. Cardiology
|
December 23, 2016
Expert consensus document: Mitochondrial function as a therapeutic target in heart failure
David A Brown, Justin B Perry, Mitchell E Allen, et al.
Circulation
|
March 17, 2004
Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL)
Douglas L Mann, John J V McMurray, Milton Packer, et al.
European Heart Journal
|
May 21, 2025
Empagliflozin enhances metabolic efficiency and improves left ventricular hypertrophy in a hypertrophic cardiomyopathy mouse model
Tomas Baka, Jarrod Moore, Fuzhong Qin, et al.
Circulation. Heart Failure
|
May 12, 2016
Developing New Treatments for Heart Failure: Focus on the Heart
Mihai Gheorghiade, Christopher J Larson, Sanjiv J Shah, et al.
Circulation
|
November 27, 2019
Unlocking the Secrets of Mitochondria in the Cardiovascular System: Path to a Cure in Heart Failure—A Report from the 2018 National Heart, Lung, and Blood Institute Workshop
Rong Tian, Wilson S. Colucci, Zoltan Arany, et al.
Page
of 11
Search research articles
Search
Showing results (101-110 of 107) with videos related to
Sort By:
Page
of 11
You have reached the last page of results.
This site can display upto 107 results.
The American Journal of Cardiology
|
August 3, 2014
Preclinical left ventricular diastolic dysfunction in metabolic syndrome
Nir Ayalon, Deepa M Gopal, Deirdre M Mooney, et al.
Lancet (London, England)
|
January 22, 2008
Results of a non-specific immunomodulation therapy in chronic heart failure (ACCLAIM trial): a placebo-controlled randomised trial
Guillermo Torre-Amione, Stefan D Anker, Robert C Bourge, et al.
Nature Reviews. Cardiology
|
December 23, 2016
Expert consensus document: Mitochondrial function as a therapeutic target in heart failure
David A Brown, Justin B Perry, Mitchell E Allen, et al.
Circulation
|
March 17, 2004
Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL)
Douglas L Mann, John J V McMurray, Milton Packer, et al.
European Heart Journal
|
May 21, 2025
Empagliflozin enhances metabolic efficiency and improves left ventricular hypertrophy in a hypertrophic cardiomyopathy mouse model
Tomas Baka, Jarrod Moore, Fuzhong Qin, et al.
Circulation. Heart Failure
|
May 12, 2016
Developing New Treatments for Heart Failure: Focus on the Heart
Mihai Gheorghiade, Christopher J Larson, Sanjiv J Shah, et al.
Circulation
|
November 27, 2019
Unlocking the Secrets of Mitochondria in the Cardiovascular System: Path to a Cure in Heart Failure—A Report from the 2018 National Heart, Lung, and Blood Institute Workshop
Rong Tian, Wilson S. Colucci, Zoltan Arany, et al.
Page
of 11